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Antibacterial marine bacterium deter 
luminous vibriosis in shrimp larvae 
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Abstract
Inhibitory activity of a marine pigmented bacterium - Alteromonas sp. - isolated from Penaeus monodon 
Fabricius larva against pathogenic and environmental isolates of Vibrio harveyi was studied. All the isolates 
were inhibited to varying degrees by Alteromonas sp. in vitro. The antibacterial substance produced by the 
Alteromonas sp. was soluble in organic solvent and closely bound to the external surface of bacterial cells. 
The antibacterial Alteromonas sp., when allowed to colonize on shrimp larvae, suppressed the activity of 
V. harveyi M3 and reduced mortality of P. monodon larvae in vivo. 
Introduction
The sea is an immense and practically 
unexploited source of new potentially 
useful biologically active substances. Given 
the fact that the oceans cover more than 
70 percent of the earth’s surface, the 
oceans are a promising source of novel 
pharmacologically active compounds. 
Although macro organisms of the ocean 
have proved to be good sources of novel 
bioactive metabolites, large-scale produc-
tions of these bioactive metabolites has 
been diffi cult (Bernan et al. 1997). Marine 
microorganisms such as bacteria and fungi 
have been reported to produce antibacte-
rial (Rosenfeld and Zobell 1947), antifungal, 
antiviral and antitumor substances (Bernan 
et al. 1997). Several earlier studies have 
suggested that such marine bacteria can be 
used to combat epizootics in aquaculture 
systems (Maeda and Liao 1992; Maeda 
1994; Douillet and Langdon 1994; Abraham 
at al. 2001). This paper reports on the 
extraction and characterization of an 
antibacterial substance from a pigmented 
marine bacterium and the control of Vibrio 
harveyi infection in Penaeus monodon larvae.
Materials and Methods
Bacterial strains
The antibacterial marine pigmented 
bacterium (Alteromonas sp. P7) was 
isolated from hatchery raised mysis 2 
larva of P. monodon on seawater (75%), 
yeast extract (0.3% w/v) peptone 
(0.5% w/v) - SYEP - agar supplemented 
with glycerol (0.3% v/v), and 
characterized following Baumann et 
al. (1984). The luminous Vibrio harveyi 
isolates (n = 80) were from hatchery 
raised diseased P. monodon and P. indicus 
larvae and their environment (Abraham 
et al. 1999). All the isolates were 
routinely maintained and propagated 
on SYEP agar.  An antibiotic resistant 
pathogenic luminous V. harveyi strain M3 
isolated from diseased P. indicus mysis 
larva was used for further in vitro and in 
vivo experimentation with Alteromonas 
sp. The minimal inhibitory concentration 
(MIC) of antibiotics was determined 
by the agar dilution method on Muller 
Hinton agar supplemented with 1% w/v 
sodium chloride (Abraham et al. 1997).
Vibriostatic activity of Alteromonas 
sp. P7
In vitro vibriostatic activity of Alteromonas 
sp. P7 was tested against V. harveyi isolates 
(n = 80) by cross streak technique as 
described in Lemos et al. (1985) on 
SYEP agar. Vibriostatic activity was also 
tested by double agar layer method as 
described by Dopazo et al. (1988) with 
slight modifi cation. Macro colonies of 
Alteromonas sp. P7 were developed on 
SYEP medium containing 1.2% agar by 
inoculating 3 µl of 18 h old SYEP broth 
culture. The colonies were killed after 
48 hours by exposure to chloroform 
vapour for 20 minutes. The plates with 
chloroform-killed colonies were overlaid 
with 8 ml of soft agar (SYEP broth + 0.7% 
agar) seeded with 8 µl of V. harveyi strain 
M3 grown for 18 hours in SYEP broth. 
The plates were incubated for another 24 
hours at 30±1ºC and observed for zone 
of inhibition around the macro colonies. 
Control plates without the macro colonies 
of Alteromonas sp. P7 were also used to 
evaluate the possible effect of chloroform 
on the growth of V. harveyi M3. 
Extraction of antibacterial substance 
The methods described in McCarthy et 
al. (1994) were followed by ammonium 
sulphate precipitation. Overnight culture 
of Alteromonas sp. was inoculated at 1.0% 
level into 300 ml each of SYEP broth and 
incubated at 30±1ºC for 24 hours. The 
cells were removed by centrifugation at 
10 000 rpm for 15 minutes at 4ºC. The 
supernatant fractions were subsequently 
fi ltered through a 0.22 µ membrane fi lter 
to remove cellular debris.  About 100 ml 
of cell free supernatant was concentrated 
up to 70% saturation by slow addition of 
ammonium sulphate, held overnight at 
4ºC and centrifuged at 10 000 rpm for 15 
minutes at 4ºC. The pellets were collected 
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and resuspended in 10 mM phosphate 
buffer containing 0.1 mM EDTA, pH 
7.0. The concentrated precipitate was 
exhaustively dialyzed against the same 
buffer for 24 hours at 4ºC.
The ethyl acetate extraction as described 
in Wratten et al. (1977) was followed 
with modifi cation. Alteromonas sp. was 
inoculated on to SYEP agar (1.2% agar) 
plates and incubated for 48 hours at 
30±1ºC. The cells were then gently 
scraped off and washed with sterile 
seawater (17 ppt) by centrifugation at 
10 000 rpm for 15 minutes at 4ºC. The 
cell pellet was suspended in 20 ml of 
ethyl acetate for 3 hours to extract the 
antibacterial substance. The cells were 
removed by centrifugation and the ethyl 
acetate extract was evaporated at 40-
50ºC to get a concentrated crude extract. 
In addition, the spent agar medium was 
cut into small pieces, homogenized with 
ethyl acetate (50 ml) and allowed to stand 
for 3 hours without agitation at 30±1ºC. 
The solvent was decanted and evaporated 
at 40-50ºC to get a concentrated crude 
extract of the antibacterial substance.
Inhibitory activity of the crude 
extracts in vitro  
The supernatant fraction of SYEP broth 
and crude extract of the antibacterial 
substance were tested for their inhibitory 
activity against V. harveyi strain M3 by well 
diffusion assay (Tagg and McGiven 1971). 
Wells of 6 mm diameter were made on 
hardened SYEP agar (1.2% agar) plates. 
The bottom of the wells was sealed 
with molten SYEP soft agar (0.7% agar). 
The wells were fi lled with 50 µl each of 
crude extract in ethyl acetate, dialyzed 
ammonium sulphate precipitate and cell 
free culture supernatants, and allowed 
to diffuse for 1-2 hours. The plates were 
overlaid with 8 ml of SYEP soft agar 
seeded with 8 µl of overnight-grown 
V. harveyi M3. The overlaid plates were 
incubated at 30±1ºC for 24 hours and 
examined for defi nite zone of inhibition 
(clearance) around the wells.
Inhibition of V. harveyi in vivo 
Hatchery raised P. monodon larvae of 
100 numbers each at zoea-2 stage were 
introduced into a series of troughs -3 sets 
in duplicate - fi lled with 5 l sand-fi ltered 
aged seawater (salinity: 35 ppt). The 
larvae were acclimatized for 24 hours 
and fed with Skeletonema sp. The set 1 
was inoculated with Alteromonas sp. P7 at 
a level of 106 cells/ml of rearing medium 
to facilitate attachment/colonization on 
the larvae. Vibrio harveyi M3 was then 
inoculated into the troughs of set 1 after 
3 hours of addition of Alteromonas sp. P7 
and also in set 2 at a level of 104 cells/ml 
of rearing medium to serve as positive 
control. The set 3 received no bacterial 
inoculums and served as negative control. 
Mortality was recorded till the larvae 
reached post-larvae 1 stage and no water 
exchange was done during that period. 
Results and Discussion
The antibacterial bacterium from 
P. monodon larva was a Gram negative, 
motile, cytochrome oxidase positive 
rod, which produced an orange pigment 
on seawater-based medium. Loss in 
pigmentation was observed when grown 
on non-seawater based medium. It was 
capable of growth up to 6% sodium 
chloride (NaCl). It failed to grow on 
thiosulphate citrate bile salt sucrose agar, 
MacConkey agar and medium without 
NaCl. This bacterium was negative 
for luminescence, amylase, gelatinase, 
catalase, urease, iodole production 
and nitrate reduction, and positive 
for citrate utilization. Carbohydrates 
such as arabinose, dextrose, galactose, 
lactose, mannitol, sorbitol, and sucrose 
were not utilized. These characteristics 
and a comparison with Baumann et al. 
(1984) place this bacterium under the 
genus Alteromonas and designated as 
Altreomonas sp. P7. As seen in Table 1, 
all the pathogenic and environmental 
V. harveyi isolates were sensitive to 
Altreomonas sp. P7, although with varying 
degrees of inhibition. Antibacterial activity 
among marine bacteria is a well-known 
phenomenon and demonstrated in a 
number of studies (Rosenfeld and Zobell 
1947; Anderson et al. 1974; Lemos et al. 
1985; Dopazo et al. 1988; McCarthy et al. 
1994).
The shrimp larval pathogen V. harveyi 
M3 was resistant to antibiotics such 
as chloramphenicol, erythromycin, 
furazolidone, neomycin, prefuran, 
streptomycin, sulphadiazine and 
trimethoprim, exhibiting high MIC values 
(Table 2). The antibiotic resistant V. harveyi 
M3 exhibited a zone of inhibition of 
4.00±0.25 and 7.25±0.83 mm by cross 
streak and double agar layer methods, 
respectively (Table 3). The cell free 
supernatants and the dialyzed ammonium 
sulphate precipitate did not display any 
Source
Numbers tested / 
Numbers inhibited
(n=80)
Percent isolates exhibiting zone
1-10 mm >10 mm
Diseased shrimp
Seawater
39/39
41/41
51.28 
43.90 
48.72 
56.10 
Table 1. In-vitro inhibitory activity of Alteromonas sp. against luminous Vibrio harveyi 
by cross streak technique.
Antibiotics MIC µg/ml
Chloramphenicol
Ciprofl oxacin
Erythromycin
Furazolidone
Gentamycin
Nalidixic acid
Neomycin
Oxytetracycline
Prefuran
Polymyxin B
Streptomycin
Sulphadiazine
Trimethoprim
75.00
0.39
75.00
100
12.50
6.25
50.00
6.25
50.00
25.00
100
>100
>100
Table 2. Minimal inhibitory 
concentration (MIC) of antibiotics 
against Vibrio harveyi M3.
NAGA, WorldFish Center Quarterly  Vol. 27 No. 3 & 4 Jul-Dec 200430
articles
inhibitory activity against V. harveyi M3. 
No loss in antibacterial activity was 
observed on treatment with proteolytic 
enzyme, trypsin 2 000 units/g by modifi ed 
spot-on-the-lawn method (Okereke and 
Montville 1991) on SYEP agar (Table 3). 
This indicated that the antibacterial 
substance might not be proteinaceous 
in nature although certain strains of 
Alteromonas have been reported to 
produce proteinaceous antibacterial 
substances (McCarthy et al. 1994). In an 
earlier study by Rosenfeld and Zobell 
(1947), the inhibitory activity was not 
expressed when cell free preparations 
were used, as the inhibitory compounds 
did not diffuse into the aqueous 
environment.
The antibacterial substance produced 
by Alteromonas P7 was recovered from 
the cells and the spent agar medium 
using ethyl acetate as solvent (Table 
4). Burkholder et al. (1966) observed 
better antibiotic production by a 
marine bacterium on solid media. Since 
the antibacterial substance could be 
recovered from both the cells and 
spent agar medium, it can be inferred 
that the antibacterial substance may 
be bound to the outer cell surface and 
secreted into the solid medium. This 
corroborates with earlier observations 
(Rosenfeld and Zobell 1947; Lemos et 
al. 1985) that the inhibitory compounds 
remain closely bound to the cell. The 
production of antibiotic substance by 
Alteromonas sp. was observed to be a 
growth-associated phenomenon in an 
earlier study and probably released 
as secondary metabolite into the 
surrounding environment (Abraham et 
al. 2001). The specifi c role of the cell wall 
in the secretion process is still unknown. 
However, according to Lemos et al. 
(1985), if the antibiotics remain bound 
to the cells, they can be excreted slowly 
and continually to the environment, 
preventing colonization of the adjacent 
space by competitors. A rapid release 
of the antibiotic substance by antibiotic 
bacteria probably would not provide 
them any competitive advantage because 
it would be immediately washed away 
by the seawater. The observations of 
the present study further indicated 
that the antibacterial compound of 
Alteromonas P7 could be an organic 
compound or polysaccharide as other 
antibacterial substances recovered from 
marine bacteria using ethyl acetate have 
turned out to be a pyrole (Burkholder 
et al. 1966) or quinolinol (Wratten et al. 
1977) or tyrosol and isatin (Gil-Turnes 
and Fenical 1992) or a polysaccharide 
(Anderson et al. 1974). 
The data presented in Table 5 revealed 
that the antibacterial bacterium, 
Alteromonas sp. P7 was capable of reducing 
the luminous V. harveyi induced mortality 
signifi cantly in P. monodon larvae in vivo. 
Vibrio harveyi M3 affected about 72±3% 
mortality in P. monodon larvae in 72 
hours. The V. harveyi induced mortality 
was, however, reduced signifi cantly 
(P<0.01) to 59±3% in larvae colonized 
prior with antibacterial bacterium, 
Alteromonas sp. P7. Similar effects have 
been observed with benefi cial marine 
bacteria in protecting the embryos of 
Homarus americanus (Gil-Turnes and 
Fenical 1992), larval rearing of oyster 
(Douillet and Langdon 1994), penaeid 
shrimp and larvae (Maeda and Liao 
1992; Maeda 1994; Abraham et al. 2001). 
Signifi cant differences in the mortalities 
of shrimp larvae of Alteromonas and V. 
harveyi inoculated group and uninoculated 
control group were observed (P<0.05), 
probably due to the fouling of bacteria 
on gills and/or other appendages. The 
results of the present study, thus, evinced 
that the antibacterial bacterium isolated 
from shrimp larva inhibited shrimp larval 
pathogen V. harveyi both in-vitro and in-vivo. 
Therefore, the colonization/attachment 
of non-pathogenic antibacterial marine 
bacterium, not exceeding the threshold 
level, on shrimp larvae would help 
reduce larval mortalities in hatcheries by 
Values are mean ± standard deviation of four observations.
* No inhibition was observed on control plates without Alteromonas sp. macrocolonies.
Table 3. Inhibitory activity of Alteromonas sp. against Vibrio harveyi M3 on seawater 
yeast extract peptone agar.
Technique Zone of inhibition (mm)
Cross streak method
Double agar layer method*
Spot-on-the-lawn method with or without trypsin 2000 units/g
4.00 ± 0.25
7.25 ± 0.83
5.75 ± 0.30
Treatment
Zone of inhibition in test 
wells (mm)
Cell free supernatant of SYEP broth 
Crude extract of ammonium sulphate precipitate, dialyzed from 
SYEP broth 
Ethyl acetate crude extract from whole bacterial cell
Ethyl acetate crude extract from spent SYEP agar 
0
0
21.50 ± 1.12
1.00 ± 0.50
Table 4. Inhibitory activity of the crude extracts of the antibacterial substance 
from Alteromonas sp. on Vibrio harveyi M3.
SYEP: Seawater yeast extract peptone broth. Control wells with 50 µl each of sterile SYEP broth and 
ethyl acetate showed no zone of inhibition. Values are mean ± standard deviation of four observations.
Treatment
Mortality 
(%)
Alteromonas sp. @ 106/ml plus
Vibrio harveyi @104/ml
Vibrio harveyi @104/ml
Uninoculated control
59.0 ± 3.0a,b
72.0 ± 3.0a,c
47.0 ± 2.0b,c
Values are mean ± standard deviation of two 
observations. Mean values sharing common 
superscripts differed signifi cantly. a and c: P<0.01; 
b: P<0.05. 
Table 5. Mortalities in Penaeus monodon 
larvae: In-vivo inhibition of Vibrio harveyi 
M3 by Alteromonas sp.
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preventing attachment and proliferation 
of bacterial pathogens on them. It appears 
to be an effective way of controlling 
luminous vibriosis in shrimp larvae in lieu 
of the negative impacts of antibiotics.
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